Filing Details

Accession Number:
0000950170-24-104439
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-06 17:14:54
Reporting Period:
2024-09-05
Accepted Time:
2024-09-06 17:14:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1785279 Metagenomi Inc. MGX Biological Products, (No Disgnostic Substances) (2836) 813909017
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1995657 Pamela Wapnick C/O Metagenomi, Inc.
5959 Horton Street, 7Th Floor
Emeryville CA 94608
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-09-05 6,265 $2.88 63,051 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.
  2. The shares were sold in multiple transactions ranging from $2.80 to $2.96. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shars sold at each price.